Record ID: MS-N096
Family: Foods, botanicals and supportive care
Clinical question: Do standardized cranberry capsules prevent or reduce acute urinary symptoms during prostate or prostate-bed radiotherapy?
Evidence label: Randomized evidence; larger trial negative
Evidence at a glance
Benefit: No reproducible clinically meaningful benefit in the larger blinded trial.
Certainty: Moderate for lack of routine benefit, though formulations and comparators differed.
Risk: Usually mild gastrointestinal effects; possible warfarin interaction remains uncertain.
Cancer control: This concerns radiation cystitis symptoms and cannot establish prostate-cancer control.
What was studied
A 41-person pilot tested one capsule containing 72 mg of cranberry proanthocyanidins daily during radiotherapy and for two weeks afterward. A later multicenter double-blind trial recruited 108 men; 101 contributed analyzable data and took two cranberry or beetroot-placebo capsules each morning during treatment and for two further weeks.
Urinary frequency, control and cystitis scores were measured. Cranberry used for urinary infection prevention answers a different question from radiation-induced bladder inflammation.
What the results mean
In the pilot, cystitis occurred in 65% with cranberry and 90% with placebo, but the difference narrowly missed statistical significance (P=.058). Severe cystitis was 30% versus 45%, also not significant.
The larger blinded trial did not confirm benefit. Daytime frequency and bladder-control scores were worse with cranberry on a sensitive symptom scale. A beetroot-containing placebo complicates interpretation but does not turn the negative result into evidence for either product.
Limits and uncertainty
The trials used different symptom scales and specific capsule formulations. Juice and other products cannot be assumed equivalent.
A 2026 German S3 supportive-care update advises against cranberry juice or tablets for radiation-related urinary symptoms because efficacy has not been demonstrated.
Safety and practical context
NCCIH notes that large amounts may cause stomach upset or diarrhea. Evidence about interaction with warfarin is conflicting, so medication review matters.
Cranberry does not treat urinary obstruction or a bacterial infection. Inability to urinate, fever, flank pain or visible blood requires prompt assessment.
Questions for the care team
- Do I need a urine test or assessment for obstruction?
- Is the symptom burning, urgency, leakage or difficulty emptying?
- Does warfarin or another medicine change the safety question?
- Which supportive options fit my radiation plan?
Sources
- Cranberry pilot trial (PMID 24993395)
- Larger multicenter blinded trial
- Systematic review of radiation cystitis management (PMID 34714035)
- NCCIH cranberry safety guidance
- Connected Missing Script review
Funding and conflicts
Funding and conflicts varied by trial and were not fully verified here. The beetroot-containing comparator in the larger study is an important design detail.
Last literature search: October 21, 2026
Record appraised: October 21, 2026
This educational record is not individualized medical advice. Research doses and schedules are not personal prescriptions; do not delay or replace evidence-based cancer care.
